These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29095595)

  • 1. Matrix Metalloproteinase Cleavable Nanoparticles for Tumor Microenvironment and Tumor Cell Dual-Targeting Drug Delivery.
    Sun Z; Li R; Sun J; Peng Y; Xiao L; Zhang X; Xu Y; Wang M
    ACS Appl Mater Interfaces; 2017 Nov; 9(46):40614-40627. PubMed ID: 29095595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
    Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
    ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
    Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
    Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.
    Yao Q; Kou L; Tu Y; Zhu L
    Trends Pharmacol Sci; 2018 Aug; 39(8):766-781. PubMed ID: 30032745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor associated macrophages and angiogenesis dual-recognizable nanoparticles for enhanced cancer chemotherapy.
    Cao D; Liang L; Xu Y; Sun J; Lei M; Wang M; Wei Y; Sun Z
    Nanomedicine; 2018 Apr; 14(3):651-659. PubMed ID: 29331387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
    Mei L; Zhang Q; Yang Y; He Q; Gao H
    Int J Pharm; 2014 Oct; 474(1-2):95-102. PubMed ID: 25138251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.
    Hunt H; Simón-Gracia L; Tobi A; Kotamraju VR; Sharma S; Nigul M; Sugahara KN; Ruoslahti E; Teesalu T
    J Control Release; 2017 Aug; 260():142-153. PubMed ID: 28603028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
    Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
    Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
    Xia H; Gu G; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Song Q; Yao L; Tu Y; Chen H; Gao X; Chen J
    Bioconjug Chem; 2013 Mar; 24(3):419-30. PubMed ID: 23350619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment and Angiogenic Blood Vessels Dual-Targeting for Enhanced Anti-Glioma Therapy.
    Hu Q; Kang T; Feng J; Zhu Q; Jiang T; Yao J; Jiang X; Chen J
    ACS Appl Mater Interfaces; 2016 Sep; 8(36):23568-79. PubMed ID: 27580101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
    Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
    Liu Y; Ding X; Li J; Luo Z; Hu Y; Liu J; Dai L; Zhou J; Hou C; Cai K
    Nanotechnology; 2015 Apr; 26(14):145102. PubMed ID: 25789511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
    Gao H; Zhang Q; Yang Y; Jiang X; He Q
    Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targeting and microenvironment-responsive nanoparticles for gene delivery.
    Huang S; Shao K; Kuang Y; Liu Y; Li J; An S; Guo Y; Ma H; He X; Jiang C
    Biomaterials; 2013 Jul; 34(21):5294-302. PubMed ID: 23562171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twin-Arginine Translocation Peptide Conjugated Epirubicin-Loaded Nanoparticles for Enhanced Tumor Penetrating and Targeting.
    Zhang L; Liu F; Li G; Zhou Y; Yang Y
    J Pharm Sci; 2015 Dec; 104(12):4185-4196. PubMed ID: 26398477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy.
    Peng J; Yang Q; Shi K; Xiao Y; Wei X; Qian Z
    Adv Drug Deliv Rev; 2019 Mar; 143():37-67. PubMed ID: 31276708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment.
    Liu Z; Xiong M; Gong J; Zhang Y; Bai N; Luo Y; Li L; Wei Y; Liu Y; Tan X; Xiang R
    Nat Commun; 2014 Jun; 5():4280. PubMed ID: 24969588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
    Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
    ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.